#digital pathology market

[athenese-dx]

Unveiling The Advanced LED-Based System - ALTA ELISA Plate Reader by Athenese-Dx

ALTA ELISA Plate Reader ADX-150, based on LED with advanced digital light control technology for reliable and accurate results.

Key Features: ✅ LED LIGHT SOURCE ✔️LED for extended lamp shelf life ✔️Digital light control technology

✅ HIGHER LINEARITY ✔️Very-high linearity up to 3.5 OD

✅ FLEXIBLE PRINTING OPTIONS ✔️Supports Internal & External USB printers ✔️Easy printing through network printer connected via LAN/Wi-Fi

✅ SEAMLESS COMMUNICATION & DATA EXPORT ✔️Export results in CSV, Excel & PDF

✅ 7-inch LCD Touch screen display ✅ Easy file sharing through Local Network Access for exported files ✅ Direct LIS connectivity (HL7 V 2.3) without the need for middleware ✅ Colour indication for normal (Green) & abnormal (Red) test results

Buy Now → https://store.athenesedx.com/product/elisa-plate-reader/

Browse ELISA Kits → https://store.athenesedx.com/product-category/elisa-kits/

Visit → www.athenesedx.com/product/elisa-plate-reader/

athenesedx #ivd #ELISA #elisareader #microplatereader #elisaplatereader #alta #india #labtechnician #ELISAKit #medicallaboratory #MedicalLabTechnician #medicalsupplies #lifescience #pathologylab #instruments #labanalytical #labanalyticalinstrument

[bhushans]

Unveiling the Power of Data: Global Digital Pathology Market

The global  digital pathology market  is on track to witness exponential growth, with a projected valuation of USD 7,035.8 million in 2023. According to the latest market analysis, this dynamic market is expected to surge to an impressive USD 24,961.8 million by 2033, reflecting a remarkable Compound Annual Growth Rate (CAGR) of 13.5% during the forecast period from 2023 to 2033.

Digital pathology, also known as virtual microscopy, is revolutionizing the field of pathology by enabling the digitization of tissue samples for analysis, diagnosis, and research purposes. This transformative technology offers numerous advantages over traditional microscopy, including enhanced accuracy, efficiency, and remote accessibility of pathology data.

The market for digital pathology is expanding due to two main factors: the growing use of advanced analytics in pharmaceutical and medical tests. The industry is expanding as a result of the application of analytics for fraud detection and claim management by government agencies and healthcare financing companies.

Request Your Detailed Report Sample With Your Work Email: https://www.futuremarketinsights.com/reports/sample/rep-gb-124

Surge in R&D in Digital Pathology to Augment Sales in Forthcoming Years

In recent years, the digital pathology industry has increased investments in biosimilar research and development initiatives, primarily for cancer treatment and Covid-19 treatment, which have substantially fuelled the market expansion.

Contract Research Organizations (CROs), in-vitro diagnostics (IVD) laboratories, clinical laboratories, and regulatory consultants are being assigned biosimilar development responsibilities by pharmaceutical corporations. These enterprises are developing in order to provide more cost-efficient solutions to their customers, requiring the use of digital pathology instruments to diagnose, research, and design effective healthcare solutions.

Cancer diagnostic Opens New Avenues for Digital Pathology Companies

Due to the sheer increasing occurrence of cancer, there is an increase in spending on digital pathology equipment. Complications arising from late cancer diagnosis, particularly in the case of blood cancer and lung cancer, necessitate the use of significant capital resources during therapy and diagnosis. The success of digital pathology in research is driving demand for these systems in the cancer research industry. This is also encouraging government investors to invest in digital pathology systems for clinical diagnosis. A significant amount of money is spent on cancer diagnosis and therapy monitoring. This explains why digital pathology solutions are in high demand.

Competitive Landscape

Danaher Corporation

F. Hoffmann-La Roche AG

Huron Technologies International Inc.

Koninklijke Philips N.V.

Olympus Corporation

Hamamatsu Photonics K.K.

Carl Zeiss AG

Nikon Corporation

3DHISTECH Ltd.

Hologic Inc.

PerkinElmer, Inc.

Visiopharm

OptraSCAN, Inc.

Inspirata, Inc.

Sectra AB

Some of the recent developments in digital pathology market are as follows:

In May 2021, Leica Biosystems joined the European Society for Digital and Integrative Pathology (ESDIP) to assist pathology labs in developing laboratories in accordance with modern digital pathology instruments.

In March 2021, Roche inked a comprehensive merger agreement with GenMark Diagnostics to broaden its product and distribution channel for European consumers.

Key Segments:

Digital Pathology by Product Type:

Digital Pathology Equipment

Whole Slide Scanners

Brightfield Slide Scanners

Fluorescence Slide Scanners

Combination Slide Scanners

Clinical Microscope

Tissue Microarrays

Digital Pathology Software

Image Viewing and Analysis Software

On-premise

Cloud-based

Digital Pathology Information Systems

On-premise

Cloud-based

Digital Pathology Services

Installation and Integration Services

Consulting Services

Maintenance and Validation Services

Digital Pathology by Application:

Clinical Pathology

Molecular Diagnostics

Basic & Applied Research

Drug Development

Others

Digital Pathology by End User:

Hospitals

Diagnostic Laboratories

Pharmaceutical & Biotechnology Companies

Forensic Laboratories

Research Institutes

Contract Research Organizations (CROs)

Clinics

[iruchakalyan]

The Global Digital Pathology Market was valued at USD 1.4 Billion in 2023 and is estimated to reach USD 2.3 Billion by 2032, growing at a CAGR of 10.9 % from 2024 to 2033.

Digital Pathology includes the acquisition, sharing, and interpretation of pathologic information. It is the sub-field of pathology that focuses on data management based on information received from digitalized specimens. Digital pathology is mainly used by large biopharmaceuticals and top clinical research organizations to streamline drug development processes in discovery, clinical trials, and pre-clinical. The growth in digital pathology is boosted due to growing awareness of cancer diagnosis, growing applications of drug development, and precision medicines is propelling the market growth.

Emerging countries are expected to offer potential opportunities to the key players during the coming years.

To a certain extent, the market growth can be hampered due to increasing costs in the digital pathology systems.

Economic Impact of Covid-19:

The analysis of the COVID-19 recovery trajectory provides an overview of the main strategies that industries are implementing to respond to and recover from the economic crisis. It also focuses on the post-pandemic and pre-pandemic era of the Global Digital Pathology Market through PEST analysis, SWOT, Quantitative and Qualitative analysis, Attractive analysis, and DROs. Innovations by market players and an increasing number of products will propel the growth of this market.

Digital pathology hardware i.e. scanners are the major restraint in this market. The development of affordable scanners is expected to grow this market, as private medical practices can’t afford expensive digital pathology systems. Therefore, the invention of cost-effective scanners will allow small players to move towards the digitization of pathology workflow creating new opportunities in the digital pathology market.

Key Players:

Thermo Fisher Scientific Inc

Apollo Enterprise Imaging Group

Huron Technologies International Inc.

PROSCIA

GE Healthcare

Propath UK Limited

Roche Tissue Diagnostics & Visiopharm

Indica Labs

Akoya Biosciences

Ibex Medical Analytics

Sectra AB

Inspirata

Mikroscan Technologies

Olympus Corporation

Others

Know More- https://nexbindinsight.com/pharmaceutical-and-healthcare/the-global-digital-pathology-market-was-valued-at-usd-billion

[dipikazz]

Digital Pathology Market: Examined in New Market Research

A report has come out that gives an outline of the Digital Pathology Industry alongside a definite clarification that gives a lot of understanding. The meaning of the item/administration alongside the various utilizations of this item/administration in various end-client ventures can be tracked down in the outline. There is additionally a lot of data that features the development direction of the Digital Pathology Market. The data gives areas of strength for a to the market to be sectioned into various fragments. Truth be told, the data additionally shows the greatest portion of the overall industry during the estimate time frame by 2028.

Notwithstanding the abovementioned, the data depends on the accomplices that are exceptionally serious, vital participants as well as their market income in the conjecture long periods of 2022 to 2028. There is likewise areas of strength for an on item incomes, deals, item classes and, surprisingly, the items that are encountering the most footing. Thusly, the report likewise talks about the adequacy of the Ground Taking care of Administrations Market alongside its development during the conjecture time of 2030. Other significant characteristics of the market have been considered and broke down across numerous turns of events. This portrays a strong hold of the market for the impending time frame.

The central participants canvassed in this review

1.            Koninklijke Philips N.V.

2.            Nikon Corporation

3.            Perkin Elmer, Inc.

4.            Indica Labs

5.            3DHISTECH Ltd.

6.            Hamamatsu Photonics K.K.

7.            F. Hoffmann-La Roche Ltd

8.            Visiopharm A/S

9.            Glencoe Software, Inc.

10.          Danaher Corporation

Division

The Digital Pathology Market has been fragmented based on various perspectives. The market is additionally divided by district. This division has been followed fully intent on separating bits of knowledge into the Ground Dealing with Administrations Market that are both nitty gritty as well as precise. The Advanced Pathology Market has been divided into Latin America, North America, Asia Pacific, Europe, and the Center East and Africa based on district

Research Philosophy

The report has its foundations most certainly set in exhaustive procedures given by the capable information experts. The exploration approach includes the assortment of data by examiners just to have them contemplated and separated completely trying to give huge expectations about the market over the audit period. The examination cycle further incorporates interviews with driving business sector powerhouses, which makes the essential exploration applicable and useful. The market techniques embraced in the report offer exact information examination and gives a visit through the whole market. Both essential and auxiliary ways to deal with information assortment have been utilized. What's more, freely accessible sources like SEC filings, yearly reports, and white papers have been utilized by information investigators for an adroit comprehension of the market. The exploration strategy plainly mirrors an aim to remove an exhaustive perspective available by having it broke down against numerous boundaries. The esteemed sources of info upgrade the report and proposition an edge over the friends.

Drivers and Requirements

The Digital Pathology Market rests joined with the rate of directing players who hold financing to the market's development essentially consistently. The report concentrates on the worth, volume patterns, and the valuing construction of the market so it could foresee most extreme development later on. Additionally, different stifled development variables, limitations, and potential open doors are likewise assessed for the high level review and ideas of the market over the evaluation period.

The Understanding Accomplice's devoted examination and investigation group comprise of experienced experts with cutting edge measurable mastery and proposition different customization choices in the current review.

Significant Highlights of Advanced Pathology Market Report:

•             Save and diminish time completing section level exploration by recognizing the development, size, driving players and fragments in the Advanced Pathology market.

•             Features key business needs to help organizations to realign their business systems.

•             The vital discoveries and proposals feature significant moderate industry patterns in the Digital Pathology market, subsequently permitting players across the worth chain to foster powerful long-haul procedures.

Gratitude for perusing this article; you can likewise redo this report to get select parts or district wise inclusion with locales like Asia, North America, and Europe.

[delicatemagazinedreamer]

Digital Pathology Market Is Estimated To Witness High Growth Owing To Increasing Adoption of Telepathology

The global Digital Pathology Market is estimated to be valued at US$ 884.4 million in 2023 and is expected to exhibit a CAGR of 12.2% over the forecast period, as highlighted in a new report published by Coherent Market Insights. A) Market Overview: Digital pathology is an advanced technology that involves the management, storage, and interpretation of pathology information in a digital format. It eliminates the need for physical slides and allows easy access to patient data for analysis and diagnosis. This technology offers numerous advantages such as enhanced accuracy, faster turnaround time, remote consultation, and improved collaboration among pathologists. The need for digital pathology solutions is driven by the rising demand for efficient diagnostic tools and the increasing complexity of pathological slides. B) Market Key Trends: One key trend in the global Digital Pathology market is the increasing adoption of telepathology. Telepathology allows pathologists to remotely access and interpret pathology images, enabling them to provide expert opinions and consultations regardless of geographical barriers. This trend has gained significant momentum due to the COVID-19 pandemic, which has increased the need for remote work and virtual healthcare solutions. Telepathology not only improves access to pathology expertise in underserved areas but also facilitates multi-disciplinary collaboration and enables faster diagnosis and treatment decisions. C) PEST Analysis: - Political: Regulatory policies and guidelines play a crucial role in the adoption of digital pathology solutions. Governments worldwide are focusing on enhancing healthcare infrastructure and promoting digitization in healthcare. - Economic: The growing healthcare expenditure and increasing burden of chronic diseases are driving the demand for digital pathology solutions. Moreover, advancements in technology and cost reduction of digital pathology systems are also contributing to market growth. - Social: The growing geriatric population, increasing prevalence of chronic diseases, and rising awareness about personalized medicine are factors driving the need for accurate and efficient diagnostic tools like digital pathology. - Technological: Advancements in image analysis software, machine learning, and artificial intelligence have revolutionized digital pathology. These technologies enable automated analysis, better accuracy, and faster diagnosis, thereby boosting market growth. D) Key Takeaways: - The global Digital Pathology Market Demand is expected to witness high growth, exhibiting a CAGR of 12.2% over the forecast period, due to the increasing adoption of telepathology. - North America is the fastest-growing and dominating region in the digital pathology market, attributed to the presence of well-established healthcare infrastructure, a high burden of chronic diseases, and a supportive regulatory environment. - Key players operating in the global Digital Pathology Market include Leica Biosystems Nussloch GmbH, Olympus Corporation, F. Hoffmann-La Roche Ltd., Merck KGaA, GE Healthcare, Mikroscan Technologies, Inc., Koninklijke Philips N.V., Sectra AB, Propath UK Limited, Inspirata, Inc., Hamamatsu Photonics, Inc., OracleBio Limited, MD Biosciences, Aiforia, Xybion Digital Inc., and Nucleai, Inc. In conclusion, the global Digital Pathology Market is experiencing significant growth due to the increasing adoption of telepathology and advancements in technology. This market has immense potential to improve diagnostic accuracy, enhance collaboration among pathologists, and facilitate remote consultations. As healthcare systems continue to embrace digitization, the demand for digital pathology solutions is expected to soar in the coming years.

[versatile-blogger-1]

Digital Pathology Market Is Estimated To Witness High Growth Owing To Increased Adoption Of Digital Pathology Solutions And Rising Demand For Efficient Diagnostic Methods

A) Market Overview:

Digital pathology is a revolutionary technology that involves the capturing, managing, and interpreting of digital images from pathology slides. It eliminates the need for physical slides by digitizing them, allowing pathologists to view and analyze them using computer platforms. Digital pathology enables efficient storage, retrieval, and sharing of pathology images, making it a valuable tool in research, education, and diagnosis. The market offers various products such as scanners, software, and storage systems that enable the conversion of analog pathology slides to digital format

The global Digital Pathology Market is estimated to be valued at USD 884.4 million in 2023 and is expected to exhibit a CAGR of 12.2% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.

B) Market Dynamics:

Increasing Adoption of Digital Pathology Solutions: The adoption of digital pathology solutions is steadily increasing, driven by the advantages they offer over traditional pathology methods. These solutions enable remote access, collaboration, and quick turnaround time for diagnosis, leading to improved patient outcomes. Additionally, digital pathology eliminates the risk of slide loss or damage and allows easy sharing of images for second opinions or consultation.

Rising Demand for Efficient Diagnostic Methods: The growing burden of diseases and the need for accurate and timely diagnoses are fueling the demand for efficient diagnostic methods like digital pathology. Digital pathology provides high-resolution images that allow pathologists to zoom in, annotate, and analyze tissue sections in detail. This enhances diagnostic accuracy and efficiency, leading to better patient management and treatment decisions.

C) Market Key Trends:

An emerging trend in the Digital Pathology Market Trends is the integration of artificial intelligence (AI) for image analysis and interpretation. AI algorithms can analyze large sets of pathology images, detect patterns, and provide automated diagnoses or assist pathologists in their diagnoses. This trend is revolutionizing the field of pathology, enabling more precise and faster diagnoses, especially in complex cases. For example, AI algorithms can identify cancerous cells, predict disease progression, and provide personalized treatment recommendations.

D) SWOT Analysis:

Strengths:

Efficient and accurate diagnosis

Improved collaboration and remote access

Weaknesses:

High upfront costs of digital pathology solutions

Limited adoption in developing regions due to infrastructure limitation

Opportunities:

Integration of AI for advanced image analysis

Expansion of digital pathology in telepathology and research applications

Threats:

Data security and privacy concerns

Resistance from traditional pathologists to switch to digital methods

E) Key Takeaways:

- The global digital pathology market is expected to witness high growth, exhibiting a CAGR of 12.2% over the forecast period, due to the increasing adoption of digital pathology solutions and the rising demand for efficient diagnostic methods.

- North America is anticipated to be the fastest-growing and dominating region in the digital pathology market, driven by advanced healthcare infrastructure, favorable reimbursement policies, and the presence of key market players.

- Key players operating in the global digital pathology market include Leica Biosystems Nussloch GmbH, Olympus Corporation, F. Hoffmann-La Roche Ltd., Merck KGaA, GE Healthcare, Mikroscan Technologies, Inc., Koninklijke Philips N.V., Sectra AB, Propath UK Limited, Inspirata, Inc., Hamamatsu Photonics, Inc., OracleBio Limited, MD Biosciences, Aiforia, Xybion Digital Inc., and Nucleai, Inc.

In conclusion, the digital pathology market is experiencing significant growth due to the increasing adoption of digital pathology solutions and the rising demand for more efficient diagnostic methods. The integration of AI in digital pathology and the expansion of its applications present exciting opportunities for market growth. However, challenges such as high upfront costs and data security concerns need to be addressed for widespread adoption. Overall, digital pathology has the potential to transform pathology practices and improve patient outcomes.

[athenese-dx]

WE ARE #HIRING! Join our team!

Apply Now → https://athenesedx.com/career/

Interested candidates kindly mail us at hr2@athenesedx.com & amit@athenesedx.com

athenesedx #IVD #mumbai #maharashtra #india #salesnmanager #areasalesmanager #regionalsalesmanager #biochemistry #hematology #instruments #ELISA #serviceengineer #applicationspecialist #precision #medicalsupply #medicallaboratory #salesteam #sales #salesjobs #rsm #asm #hire #hiringnow #HiringAlert #lifescience #lifesciencejobs

[delvenservices]

Digital Pathology Market – Growth, Trends & Forecast 2030

Growth of the global digital pathology market is majorly driven by the increase in the prevalence of cancer; a rise in the demand for accurate diagnostics, and the development of new digital pathology systems by a large number of key players. According to a report published by Medscape, chronic diseases can be associated with a higher mortality rate. The fundamental cause for the development of advanced diagnostic solutions is the rise prevalence of cardiovascular disorders. Thus, as the prevalence of chronic and cardiovascular diseases rises, the need for digital pathology systems increases driving the growth of the digital pathology market.

The global Digital Pathology Market size is 799.296 million USD in 2022 and is projected to reach a CAGR of 8.6% from 2023-2030.

On the other hand, the high cost of a typical digital pathology system, coupled with the lack of skilled personnel to operate them is expected to limit the adoption of these systems.  The cost, which includes a slide scanner, an image server, and software, costs around USD 500,000 to USD 700,000.  While in the Asia Pacific, the average price is around USD 110,000 to USD 130,000. Although large hospitals with significant capital budgets can afford these systems, pathologists and academic institutes with limited budgets or IT support often cannot afford them, this significantly restricts the Digital Pathology Market.

To Understand Business Strategies, Request for a Sample Report at: https://www.delvens.com/get-free-sample/digital-pathology-market-trends-forecast-till-2030

Delvens Industry Expert's Standpoint

Due to its ability to ascertain and comprehend the causes of diseases, digital diagnosis plays a significant role in the diagnosis of many chronic diseases. The efficiency, effectiveness, and safety of disease diagnosis in pathology laboratories are improved by the integration of digital pathology with digital tools like barcoding, specimen tracking, digital dictation, and others. Multiple pathologists can instantly share entire slides through a digital pathology platform to contribute to a case at once. The rise in the incidence of cancer, the requirement for precise diagnoses, and the creation of innovative digital pathology systems are the primary factors driving the worldwide market for digital pathology.

Regional Analysis:

North America accounted for the largest share of the digital pathology market during the forecast period. The increasing prevalence of cancer, rising demand for quality diagnostics, the introduction of favorable reimbursement policies, and the implementation of favorable initiatives by the governments in the US and Canada are major factors driving the growth of the digital pathology market in North America.

To Grow Your Business Revenue, Make an Inquiry Before Buying at: https://www.delvens.com/Inquire-before-buying/digital-pathology-market-trends-forecast-till-2030

Key Findings

The scanners segment is further segmented into Scanners, Software, and Storage systems. The scanners segment is expected to hold the highest orientation during the forecast period. The large share of the scanners segment can be attributed to the high price of scanners and the increasing adoption of digital pathology solutions.

The type segment is further segmented into Human Pathology and Veterinary Pathology. The human pathology segment is anticipated to hold the largest share during the forecast period. This is due to the increasing number of cancer research activities and growing collaborations among research institutes, universities, and pathology laboratories.

The application segment is further fragmented into Drug Discovery, Disease Diagnosis, and Training & Education. The drug discovery segment is expected to reach the highest CAGR during the forecast period. Growth in R&D expenditure fuelled by the need for numerous preclinical and clinical studies performed during the drug discovery and development process is a major factor responsible for market growth.

The end-user segment is further segmented into Pharmaceutical & Biotechnology Companies, Hospitals and Reference Laboratories, and Academic & Research Institutes. The segment is expected to hold the largest share in Pharmaceutical & Biotechnology Companies. The large share of this segment can be attributed to the increasing use of digital pathology for drug discovery studies and drug toxicology testing. Biotechnology companies also use digital pathology for biobanking, biopharmaceutical studies, molecular assays, and the development of individualized medicine.

Direct Purchase of Digital Pathology Market Report at: https://www.delvens.com/checkout/digital-pathology-market-trends-forecast-till-2030

According to the research done the top players of Digital Pathology market are:

3DHISTECH LTD, Danaher Corporation, Glencoe Software Inc., HAMAMATSU Photonics K.K, Indica Labs Inc., Koninklijke Philips N.V, Nikon Corporation, Perkinelmer Inc., Roche, and VisoPharma A/S are the major players operating in Digital Pathology Market.

Recent Developments in the Digital Pathology Market:

In September 2021, Visiopharm (Denmark) and Agilent Technologies, Inc. (US) collaborated to co-market Visiopharm’s portfolio of CE-IVD marked AI-driven Precision Pathology software and Agilent’s automated pathology staining solutions portfolio.  

In August 2021, Sectra AB (Sweden) and University Medical Center Utrecht (Netherlands) signed an agreement under which UMC uses Sectra’s pathology module for effective multidisciplinary discussions among pathologists and radiologists.

Reasons to Acquire this trending report of Digital Pathology Market:

Increase your understanding of the market for identifying the best and most suitable strategies and decisions on the basis of sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends, and factors  

Gain authentic and granular data access for Digital Pathology Market so as to understand the trends and the factors involved in changing market situations  

Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future  

In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns

Read related Healthcare Reports:

2030 Forecast: Fitness Equipment Market  https://www.delvens.com/report/fitness-equipment-market-trends-forecast-till-2030

Dermatology Device Market https://www.delvens.com/report/dermatology-devices-market-trends-forecast-till-2030

Robot Assisted Surgery Market https://www.delvens.com/report/robot-assisted-surgery-market-trends-forecast-till-2030

Explore: Who We Are..

Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on country, regional and global business environment. We have a database for more than 45 industries in more than 115+ major countries globally.

Delvens database assists the clients by providing in-depth information in crucial business decisions. Delvens offers significant facts and figures across various industries namely Healthcare, IT & Telecom, Chemicals & Materials, Semiconductor & Electronics, Energy, Pharmaceutical, Consumer Goods & Services, Food & Beverages. Our company provides an exhaustive and comprehensive understanding of the business environment.

Contact Us:

UNIT NO. 2126, TOWER B,

21ST FLOOR ALPHATHUM

SECTOR 90 NOIDA 201305, IN

+44-20-8638-5055

SALES@DELVENS.COM

[karanresearchlayer]

Digital Pathology Market 2023-2030 Expected Developments to be observed worldwide

Digital pathology is the practice of using digital technology to create, manage, and interpret digital images of tissue samples for diagnostic, educational, and research purposes. It involves the acquisition, processing, and analysis of digital images of pathology specimens, which are then viewed and interpreted by pathologists using computers.

Some key aspects of digital pathology include:

For Download Sample Report Click Here: https://www.globmarketreports.com/request-sample/234012

Digital slide scanning: Pathology slides are digitized using high-resolution scanners to create high-quality, digital images that can be viewed and analyzed on a computer.

Image management: Digital pathology systems include software for managing and organizing digital images, including storage, retrieval, and archiving.

Image analysis: Digital pathology allows for advanced image analysis techniques, such as computer-aided diagnosis and automated image recognition, to aid in the interpretation of images.

Telepathology: Digital pathology enables remote consultation and collaboration between pathologists, allowing for improved access to pathology expertise and faster turnaround times for diagnoses.

Digital pathology has several advantages over traditional pathology methods, including:

Improved accuracy and precision: Digital pathology allows for more precise and accurate measurements and analysis of pathology specimens.

Increased efficiency: Digital pathology enables faster and more efficient slide scanning and image analysis, leading to faster turnaround times for diagnoses.

Enhanced collaboration and education: Digital pathology enables remote consultation and collaboration between pathologists, as well as improved access to pathology expertise for medical education and training.

Improved patient care: Digital pathology allows for more accurate and timely diagnoses, leading to improved patient outcomes.

Overall, digital pathology is a rapidly evolving field that has the potential to transform the practice of pathology, improving accuracy, efficiency, and patient care.

[mitinosh]

Digital pathology Market Overview, Size, Share Analysis, Key Companies, and Forecast To 2028

[mrunalnerkarblog]

The Global Digital Pathology Market Continues To Grow Owing To the Recent Developments Done By Central Market Players in the World

Market Overview:

Digital pathology also offers more options for viewing, marking, and sharing images. It makes it easier for pathologists to search for cases with similar features, share slides with colleagues, and build predictive models. Using cloud storage means pathologists from around the world can access images and collaborate with one another. Using digital slides can also improve patient care. The benefits of digital pathology go beyond the ability to distribute digital slides. Digital images can be used for specialized analytics, some of which incorporate artificial intelligence. There are some downsides to digital pathology, however. It is important to weigh the benefits of digital pathology with its drawbacks. It may cause some delays in the workflow, but the benefits outweigh the disadvantages.

Competitive Landscape:

Major players operating in the global digital pathology market include Paige, Motic, Mikroscan Technologies, Kanteron Systems, Proscia Inc., PathAI, Inspirata, Inc., KONFOONG BIOTECH INTERNATIONAL CO., LTD., Glencoe Software, OptraSCAN, Sectra AB, Objective Pathology Services, Indica Labs, Corista, Akoya Biosciences, Aiforia Technologies Oy, Visiopharm A/S, Huron Digital Pathology, XIFIN, Inc., Apollo Enterprise Imaging, 3DHISTECH, F. Hoffmann-La Roche Ltd., Hamamatsu Photonics, Koninklijke Philips N.V., and Leica Biosystems.

Key Market Drivers:

Increasing developments related to the global digital pathology market are expected to augment the growth of the market, For instance, in September 2021, Visiopharm and Agilent Technologies, Inc. partnered in order to co-market Visiopharm’s CE-IVD marked Artificial Intelligence-driven Precision Pathology software, along with the automated pathology staining solutions of Agilent. Although digital pathology has only just begun to enter the clinical world, it already offers many benefits. Digital pathology tools can help pathologists make faster, more accurate diagnoses. They can also share results with other experts, and they can be shared in educational settings. The increasing expansion of pathology labs in the world is estimated to enhance the growth of the global digital pathology market.

Covid-19 Impact Analysis:

During the COVID-19 pandemic, there have been several developments in the global digital pathology market. For instance, in April 2021, Paige.AI, Inc. and Leica Biosystems collaborated on Paige’s AI-enabled research software to aid in grading and tumor detection.  

Key Takeaways:

·         North America is expected to dominate the growth of the global digital pathology market, owing to the recent developments by key players in the region. For instance, in August 2020, Bio-Techne Corporation and Leica Biosystems collaborated in order to automate RNAscope COVID-19 probes on Leica’s BOND RX platform for research purposes.

·         Europe is estimated to witness high growth in the global digital pathology market, owing to the high expansion of key market players in the region. For instance, in August 2021, University Medical Center Utrecht and Sectra AB signed went in a partnership, in order to use Sectra’s pathology module.